Clinical Trials Browser

Unknown × OTHER × ensartinib × Clear all

NCT03574402 2022-12-06

TRUMP

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05380024 2022-08-18

A Study of Ensartinib as Neoadjuvant Therapy for Patients With ALK Positive Resectable Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung

NCT05178511 2022-01-05

ERSGATR

Phase 2 Unknown

The Diagnosis Was ALK Positive NSCLC